FDA Authorizes Drug Combination for Treatment of COVID-19 - COVID-19 Clinical Trial
Breaking News | COVID-19

FDA Authorizes Drug Combination for Treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

In a clinical trial of hospitalized patients with COVID-19, baricitinib, in combination with remdesivir, was shown to reduce time to recovery within 29 days after initiating treatment compared to patients who received a placebo with remdesivir. The safety and effectiveness of this investigational therapy for use in the treatment of COVID-19 continues to be evaluated. Baricitinib is not authorized or approved as a stand-alone treatment for COVID-19.


CDC Warns Against Thanksgiving Travel as Covid-19 Cases Spike

Americans should avoid travel for Thanksgiving, the Centers for Disease Control and Prevention recommended Thursday. It was a last-minute attempt by the nation’s leading public health agency to curb what’s sure to be yet another dangerous spike in Covid-19 cases if families gather next week. “In the last week, we’ve seen over a million new cases,” Erin Sauber-Schatz, head of the CDC’s Community Interventions and Critical Populations Task Force, said Thursday on a call with reporters. “Thanksgiving is a week away.”

Still, the CDC stopped short of mandating that Americans refrain from traveling. “It’s not a requirement. It’s a recommendation for the American public to consider,” Dr. Henry Walke, the CDC’s Covid-19 incident manager, said on the call. “Right now, especially as we’re seeing this sort of exponential growth in cases, and the opportunity to translocate disease or infection from one part of the country to another, it leads to our recommendation to avoid travel at this time.”

Share this:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on reddit
Reddit
Share on email
Email
Scroll to Top

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.